Username
Password
Forgot your username?
Forgot your password?
Create an account
Home
|
About Us
|
Contact Us
FDA Calendar
FDA Calendar
How To Use The FDA Calendar To Invest
Key Tips On Using The FDA Calendar
Articles
Featured Content
FDA News and Approvals
Most Popular
Latest News
Breaking News
User Submitted Articles
Contribute an Article
GlobeNewswire
News and Analysis
About Us
Support
Help Desk
Sector News
FDA Approves Genentech’s Cotellic™ in Combination With Zelboraf®; FORUM Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 11, 2015.
» Read More
MediciNova Receives Notice of Allowance for New Patent Covering MN-221; FDA Grants TEVA Therapy Designation for SD-809
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 10, 2015.
» Read More
Capricor Presents Positive Data from the DYNAMIC Clinical Trial; Collegium Announces FDA Tentative Approval for Xtampza(TM) ER
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 9, 2015.
» Read More
BioMedReports.com
More Articles...
MiMedx Issues Document Related to Misinterpretations of FDA's Proposed Draft Guidance; Genocea Presents Positive Findings from ATLASTM Immuno-Oncology Research Collaboration
Active Stock: Cerner Corporation, PharMerica Corporation, Aratana Therapeutics, Novartis, Horizon Pharma
Going to the Next Stage in Revenues
TESARO Inc (NASDAQ:TSRO) confirms U.S. FDA Approval of VARUBI for Nausea associated with Cancer Chemotherapy
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 4 of 876
Newsletter
